Professor Stephen Davies
NON-EXECUTIVE DIRECTOR
Healthcare Experts
Summit Therapeutics
Spain
Biography
Professor Davies has served as a member of the Board of Directors since November 2013 and previously served as a member of our Board of Directors from 2004 to February 2013. Professor Davies is a distinguished academic who has been professor at the University of Oxford for over 20 years and was elected to the Waynflete Chair of Chemistry in 2006, one of the most prestigious academic posts in UK science. Professor Davies’ areas of expertise include medicinal and asymmetric chemistry and he has published extensively and received numerous awards in his field. Professor Davies co-founded Summit, as well as other University of Oxford spin-out companies. He was the founder and Non-Executive Chairman of MuOx Ltd, OxRay Ltd, and he was Non-Executive Chairman of Scientific Research Capital Ltd. He is a Founder and Non-Executive Director of OxStem Ltd, OxStem Oncology Ltd, OxStem Ocular Ltd, OxStem Cardio Ltd and OxStem Neuro Ltd, and is a Non-Executive Director of Oxford University Innovation Ltd (formerly Isis Innovation Ltd). Professor Davies received a BA in Chemistry from the University of Oxford, a DPhil in Organic Chemistry from the University of Oxford, and a DSc. in Organic Chemistry from the University of Paris.
Research Interest
chemistry